Industry › BioTech
Press Releases
New Horizon Health Announces 2021 Interim Results: Revenue Increases 317% Year-on-year, Gross Profit Margin Climbs to 56.2%
New Horizon Health Limited
Aug 21, 2021 14:02 HKT/SGT
エーザイ、抗がん剤「タズベリク(R)錠200mg」（一般名：タゼメトスタット臭化水素酸塩）を日本においてEZH2遺伝子変異陽性の濾胞性リンパ腫に係る効能効果で新発売
Eisai
Aug 16, 2021 09:00 JST
東曜藥業2021年中期營業收入大幅增長78%至人民幣2,313萬元
TOT BIOPHARM International Company Limited
Aug 13, 2021 09:00 HKT/SGT
TOT BIOPHARM 2021 Interim Revenue Surges 78% to RMB23.13 million
TOT BIOPHARM International Company Limited
Aug 13, 2021 09:00 HKT/SGT
아방스 클리니컬, 고객 가치 리더십 부문에서 프로스트&설리번 2021 아시아-태평양 CRO 최고기업상 수상
Avance Clinical
Aug 12, 2021 16:30 HKT/SGT
四环医药 (0460.HK)：响应医美专项整治，倡导中国医美“正能量”
Sihuan Pharmaceutical Holdings Group Ltd.
Aug 11, 2021 16:57 HKT/SGT
四環醫藥 (0460.HK)：響應醫美專項整治，倡導中國醫美「正能量」
Sihuan Pharmaceutical Holdings Group Ltd.
Aug 11, 2021 16:56 HKT/SGT
Sihuan Pharmaceutical (0460.HK): Respond to the special directives to combat illegal medical aesthetics services, Advocate 'Positive Energy' in China's Medical Aesthetics Industry
Sihuan Pharmaceutical Holdings Group Ltd.
Aug 11, 2021 16:55 HKT/SGT
Avance Clinical 榮獲 Frost & Sullivan 2021 年亞太地區 CRO 最佳實踐獎，以表彰其客戶價值領導力
Avance Clinical
Aug 11, 2021 07:00 HKT/SGT
Avance Clinical 荣获 Frost & Sullivan 2021 年亚太地区 CRO 最佳实践奖，以表彰其客户价值领导力
Avance Clinical
Aug 11, 2021 07:00 HKT/SGT